David Ross

Dr David Ross serves as an Adjunct Academic and Full Member at the College of Medicine and Public Health at Flinders University, and is affiliated with the Flinders Health and Medical Research Institute. He works at Flinders Medical Centre where he is responsible for diagnostic haematology services.

• MBBS (Adel)
• PhD (Adel)
• FRACP
• FRCPA

Dr Ross specializes in haematology with a focus on myeloid malignancies and minimal residual disease. His research spans chronic myeloid leukaemia, acute promyelocytic leukaemia, and myeloproliferative neoplasms including polycythaemia rubra vera. He has developed expertise in monitoring treatment responses and diagnostic methodologies for these conditions.

His recent publications demonstrate a strong focus on treatment-free remission in chronic myeloid leukemia, novel therapeutic approaches for hematologic malignancies, and global health survey data on patient experiences. His work bridges clinical practice with cutting-edge research in hematologic oncology, with particular attention to practical applications of research findings in clinical settings.

Dr Ross is an active investigator in multiple clinical trials for haematological malignancies and serves as a key member of the Australasian Leukaemia & Lymphoma Group. His collaborative work extends across Australia and New Zealand, contributing to consensus position statements on important clinical issues like COVID-19 therapeutics for patients with blood cancers.

At Flinders Medical Centre, Dr Ross leads diagnostic haematology services and contributes to the development of targeted treatment approaches for patients with various hematologic malignancies. His work on minimal residual disease monitoring has been particularly influential in the field of chronic myeloid leukemia management.